Commentary: Getting Past the Stigma and Treating Addiction as a Chronic Disease

I recently received a call from a very senior level executive at a prestigious medical school, asking for advice on how to help his 26-year-old son who has a serious heroin addiction. The son had been through five residential treatment programs over the past several years, at a cost to the family of over $150,000. The troubling thing about this call was the reason this man reached out to me. He called me because I have been public about my own son’s drug overdose – he was calling me as another affected father and had no idea that I had any familiarity with the field other than my family experience. Let’s just stop there. Consider if this high-level executive’s son had been suffering from a rare tropical disease, he would have unhesitatingly sought and received guidance from a leading medical expert – not a father who had lost his child to that disease. In this case, he was literally too ashamed to contact one of his own organization’s physicians. This extraordinary degree of stigma and sense of isolation that families still experience is unjustified and incapacitating.

So how can we get past the stigma and ensure that our children, our loved ones and everyone affected by addiction receives the appropriate care? Like other chronic medical illnesses, substance use disorders have biological, social and behavioral components; and effective management of the disease requires attention to each of these pieces (similar to Type-II Diabetes). According to the Food and Drug Administration’s standards for effectiveness, there are presently four prevention interventions, five medications and more than a dozen behavioral therapies that can be called effective in preventing, intervening early and managing substance use disorders.

We know the best outcomes are achieved when the disease is identified and intervened upon early in its trajectory. But even serious, chronic cases can be treated effectively. Self-managed, continuing recovery can, and should, be the expectable outcome from all addiction treatments.

Yet many physicians and counselors have never even heard of these medications or of many other “evidence-based” behavioral interventions and most were never trained in how to manage substance use disorders. Many specialty addiction treatment programs are not staffed to provide anything other than basic group counseling. Other programs are not licensed or funded to provide these more effective but more costly therapies and medications. And still, other programs refuse to provide them on ideological grounds. For example, there are currently three FDA-approved medications for the treatment of opioid addiction, yet less than 30 percent of addiction treatment programs offer addiction medications, and less than half of the eligible patients in those programs ever receive them.

Based on a recent review of the issue by the American Society of Addiction Medicine, the Treatment Research Institute and the Avisa Group, it appears that the most significant reasons for the lack of physician utilization are lack of training, legal and regulatory controls on the medications and, most significantly, written and unwritten insurance coverage limitations.

It is time and it is possible for individuals with emerging substance use disorders to have all available medical facts associated with the progression of addictive disease; to receive full disclosure and information about all evidence-based treatment options for their condition; and to have full access to all evidence-based therapies, medications and services.

I am hopeful that the Affordable Care Act and the Parity Legislation together will create basic fairness for individuals and families affected by the disease of addiction. But those landmark pieces of legislation are not enough to eradicate the crippling stigma still associated with this disease. We must stand together—as parents, as patients, as practitioners—to demand the already available health benefits for the prevention and treatment of substance use.

A. Thomas McLellan, Ph.D. is the CEO of the Treatment Research Institute (TRI) with more than 35 years of experience in addiction treatment research. From 2009 to 2010, he served as Science Advisor and Deputy Director of the White House Office of National Drug Control Policy (ONDCP). In 1992, he co-founded and led TRI (until his ONDCP appointment) to transform the way research is employed in the treatment of and policy making around substance use and abuse. Dr. McLellan received his B.A. from Colgate University and his M.S. and Ph.D. from Bryn Mawr College. He obtained postgraduate training in psychology at Oxford University in England. 

13 Responses

Leave your Response
    User Picture

    Syreeta

    May 9, 2016 at 10:18 PM

    Thought-provoking blog post . I was enlightened by the information ! Does someone know if my business might be able to get ahold of a template VA SCC LLC-1050 copy to fill in ?

    User Picture

    Shawn’s Mom

    September 26, 2013 at 8:41 AM

    It will be one year on Sept. 30 that I lost my beautiful 22 year old son, Shawn Sperling, to a heroin overdose. What started as an OxyContin prescription quickly became an addiction to it and then a heroin addiction because heroin is so easy to get and so cheap. Shawn was arrested for forging a doctor’s prescription for oxycontin, yet the court kept slapping him on the wrist, even though I begged the judge to court order a residential treatment program for him. The case kept getting postponed and in the meantime Shawn turned to heroin. It was a fight to get insurance to pay for a residential rehab for him and when they finally did, we had to wait fir a bed to be available. All this passing time is deadly to an addict. Shawn went into a residential treatment center and he was doing so well. Then after 45 days insurance said that that wouldn’t pay for it anymore so he was out the door. Three days later my son, Nicky found him unresponsive on the kitchen floor. It was the day before Nicky’s 24th birthday. It is almost a year since the last time we heard the laugh that won him the title of “best laugh” in the yearbook. Shawn was a loveable, popular, witty kid. We called him “Ferris Buehler” because like the character in the movie he was loved by all. Something needs to be done to change the stigma attached to addiction. It is a terrible disease and needs to be treated like a terrible disease. Insurance companies need to pay for residential, longterm treatment. Shawn wasnt ready to be released after 45 days and its disgusting that an insurance company decided that it was enough time. Insurance companies need to work with rehab facilities to ensure that beds are immediately available and that the care will be longterm. Outpatient state funded programs are a joke. Shawn’s friend got introduced to heroin waiting outside for a ride home from a state funded facility. They sell drugs openly at these places and nobody cares because they’re getting government funded and the people who are “treated” there only go because they are forced to or they lose their welfare benefits. It’s ridiculous. And when these dealers get arrested they are out within hours, ordered to attend these outpatient programs where everyone looks the other way because they’re getting state funded. Meanwhile our kids are dying. This is an epidemic and until its taken seriously by insurance companies and the courts innocent lives like my beautiful Shawn’s are lost.

    User Picture

    Thomas McLellan

    August 2, 2013 at 4:08 PM

    Thank you all for continuing this conversation. I appreciate your various perspectives. I hope these discussions will ultimately lead to public demand for improved availability and quality of care. Recognizing the need to change the way in which addiction is perceived and managed has never been more important than it is today.

    User Picture

    Rob Fleming

    July 28, 2013 at 11:15 AM

    Some wise engineers taught me many years ago that “problems are just misunderstood opportunities” (their research led to cell phones). Maybe we need to make stigma work for us.
    One of the reasons we don’t invest in early intervention; broad-based, appropriate treatment; and continuing recovery support is lack of public understanding and commitment.
    We tried the moral model (“bad addict, bad!”). We tried the medical model (“it’s a disease”). Many people can shrug these off because they think they are not affected personally. It’s time to try an economic model (“pay me now and pay me later”) that shows that all those behaviors that produce stigma also produce large, shared costs (externalities). Preventing those costs through prevention, early intervention, and effective treatment may have immediate costs, but they save far more in the long run.
    People are more sensitive to economic arguments (i.e. more selfish) in economic hard times. They are more reinforced in their opinions when they are in communities that share them, not separated by stigma (e.g. the Tea Party). We did not get significant research on AIDS and de-stigmatization of homosexuality until the families and friends of gays became a political force.
    Maybe what we need is an alliance of outrage composed of the people whose loved ones have been marginalized, let down, and discarded allied with the people outraged at the higher taxes and health care costs imposed by not dealing effectively with SUD. These folks vote and make campaign contributions. It’s time to redirect the stigma from the people with the disease and put it on the people and institutions who promote it. Let’s picket the stores that sell “bath salts”. Let’s pack the hearing rooms when SUD service budgets and alcohol taxes are considered. It’s time for “Al Anon with teeth”.

    User Picture

    Mark Schenker, Ph.D.

    July 24, 2013 at 11:27 AM

    Dr. McLellan does a fine job of noting the problems in our service delivery system and the stigma of addiction in our society. I believe there is one additional reason for the lack of dissemination of new treatment options, and that is the prevailing ideology of most current treatment programs. As a clinician with 30 years of experience in this field, I am a firm proponent of 12 Step programs for most patients struggling with recovery for addiction, and I hail the role of these programs in stimulating research and knowledge in this area. However, there is often a sense in this arena that there is no other alternative route to recovery, that any medication use is relapse, and that such other techniques are illegitimate shortcuts to recovery. I think that we need to re-think our concepts of recovery, and what routes may be valuable in reaching this goal. Bill Wilson himself was quoted as saying that “AA has no monopoly on recovery” and he personally continued to explore other modalities. It is important that we remain open minded about our approach to helping those who still suffer from addiction.

Leave a Reply

Your email address will not be published. Required fields are marked *